Piotrovsky V - Search Results

1

Galantamine population pharmacokinetics in patients with Alzheimer's disease: modeling and simulations.

Piotrovsky V, Van Peer A, Van Osselaer N, Armstrong M, Aerssens J. Piotrovsky V, et al. J Clin Pharmacol. 2003 May;43(5):514-23. J Clin Pharmacol. 2003. PMID: 12751272

2

Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patients.

Piotrovsky VK, Huang ML, Van Peer A, Langenaecken C. Piotrovsky VK, et al. Cancer Chemother Pharmacol. 1998;42(3):221-8. doi: 10.1007/s002800050808. Cancer Chemother Pharmacol. 1998. PMID: 9685057

3

Modeling the effectiveness of paliperidone ER and olanzapine in schizophrenia: meta-analysis of 3 randomized, controlled clinical trials.

Ortega I, Perez-Ruixo JJ, Stuyckens K, Piotrovsky V, Vermeulen A. Ortega I, et al. Among authors: piotrovsky v. J Clin Pharmacol. 2010 Mar;50(3):293-310. doi: 10.1177/0091270009346057. Epub 2010 Jan 7. J Clin Pharmacol. 2010. PMID: 20056804

4

Indirect pharmacodynamic response models do not require any parametric pharmacokinetic model to be fitted to effect-time data.

Piotrovsky VK. Piotrovsky VK. Methods Find Exp Clin Pharmacol. 1997 Dec;19(10):723-9. Methods Find Exp Clin Pharmacol. 1997. PMID: 9542723

5

Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation.

Hing JP, Piotrovsky V, Kimko H, Brashear HR, Zhao Q. Hing JP, et al. Among authors: piotrovsky v. Curr Med Res Opin. 2005 Apr;21(4):483-8. doi: 10.1185/030079905X38213. Curr Med Res Opin. 2005. PMID: 15899095 Clinical Trial.

6

Effect of CYP2D6 genetic polymorphism on the population pharmacokinetics of tipifarnib.

Perez-Ruixo JJ, Zannikos P, Ozdemir V, Franc MA, Francke S, Piotrovsky V. Perez-Ruixo JJ, et al. Among authors: piotrovsky v. Cancer Chemother Pharmacol. 2006 Nov;58(5):681-91. doi: 10.1007/s00280-006-0215-8. Epub 2006 Mar 17. Cancer Chemother Pharmacol. 2006. PMID: 16544144 Clinical Trial.

7

Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder.

Vermeulen A, Piotrovsky V, Ludwig EA. Vermeulen A, et al. Among authors: piotrovsky v. J Pharmacokinet Pharmacodyn. 2007 Apr;34(2):183-206. doi: 10.1007/s10928-006-9040-2. Epub 2006 Nov 29. J Pharmacokinet Pharmacodyn. 2007. PMID: 17136449 Clinical Trial.

8

Population cell life span models for effects of drugs following indirect mechanisms of action.

Perez-Ruixo JJ, Kimko HC, Chow AT, Piotrovsky V, Krzyzanski W, Jusko WJ. Perez-Ruixo JJ, et al. Among authors: piotrovsky v. J Pharmacokinet Pharmacodyn. 2005 Dec;32(5-6):767-93. doi: 10.1007/s10928-005-0019-1. J Pharmacokinet Pharmacodyn. 2005. PMID: 16328102

9

Population pharmacodynamic and pharmacokinetic modeling via mixed effects.

Piotrovsky VK. Piotrovsky VK. Curr Opin Drug Discov Devel. 2000 May;3(3):314-30. Curr Opin Drug Discov Devel. 2000. PMID: 19649865

10

Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.

Piotrovsky V. Piotrovsky V. AAPS J. 2005 Oct 24;7(3):E609-24. doi: 10.1208/aapsj070363. AAPS J. 2005. PMID: 16353940 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters